Literature DB >> 397226

Comparison of a semiautomated fluorescent immunoassay system and indirect immunofluorescence for detection of antinuclear antibodies in human serum.

C H Casavant, A C Hart, D P Stites.   

Abstract

A semiautomated fluorescent immunoassay system (FIAX) for detecting anti-nuclear antibodies (ANAs) in human serum was compared with conventional indirect immunofluorescence using microscope slides (Meloy Laboratories) coated with mouse fibroblasts. The FIAX system uses quantitative indirect immunofluorescence to measure the specific binding of ANA to a sampler coated with human epithelial cells. A total of 101 serum samples were examined for the presence of ANAs by employing both methods. At an initial 1:10 screening dilution, 23 samples were negative for ANAs by the slide method, whereas 21 samples were negative with the FIAX system. Using 2+, 3+, and 4+ subjective brightness, 68 (100%) samples were positive by the slide method, whereas 67 (98.5%) were positive with the FIAX system. ANA-positive samples were diluted twofold from 1:10 to 1:640, and positive titers were determined by both methods. Sixty (77%) of 78 positive samples titrated by FIAX came within +/-1 dilution of the titers determined by the slide method, and 75 (96%) of the samples fell within +/-2 dilutions. Results indicate good correlation between the FIAX system and indirect immunofluorescence for the detection of ANAs in human serum. The FIAX system has the advantage of speed, reproducibility, and the elimination of subjective microscopic assessment of ANA titers.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 397226      PMCID: PMC273253          DOI: 10.1128/jcm.10.5.712-718.1979

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  5 in total

1.  ANTIBODY TO RIBOSOMES IN SYSTEMIC LUPUS ERYTHEMATOSUS.

Authors:  B C STURGILL; R R CARPENTER
Journal:  Arthritis Rheum       Date:  1965-04

2.  Anti-cytoplasmic factors in the sera of patients with systemic lupus erythematosus and certain other diseases.

Authors:  H R DEICHER; H R HOLMAN; H G KUNKEL
Journal:  Arthritis Rheum       Date:  1960-02

3.  Affinity between the lupus erythematosus serum factor and cell nuclei and nucleoprotein.

Authors:  H R HOLMAN; H G KUNKEL
Journal:  Science       Date:  1957-07-26       Impact factor: 47.728

4.  Cytoplasmic antibodies in patients with systemic lupus erythematosus.

Authors:  G Wiedermann; P A Miescher
Journal:  Ann N Y Acad Sci       Date:  1965-06-30       Impact factor: 5.691

5.  Evaluation of cellular substrates for antinuclear antibody determinations.

Authors:  N Hahon; H L Eckert; J Stewart
Journal:  J Clin Microbiol       Date:  1975-07       Impact factor: 5.948

  5 in total
  4 in total

1.  Comparison of a fluorometric method with radial immunodiffusion assays for determination of complement components C3 and C4.

Authors:  M Koelle; W R Bartholomew
Journal:  J Clin Microbiol       Date:  1982-08       Impact factor: 5.948

2.  Evaluation of solid-phase immunofluorescence for quantitation of antibodies to herpes simplex virus and cytomegalovirus.

Authors:  W R Benjamin; S C Specter; T W Klein; M Hitchings; H Friedman
Journal:  J Clin Microbiol       Date:  1980-10       Impact factor: 5.948

3.  Detection of antibodies to Legionella pneumophila in immune guinea pig serum by solid-phase immunofluorescence.

Authors:  F R Vogel; T W Klein; S C Specter; M Hitchings; H Friedman
Journal:  J Clin Microbiol       Date:  1981-04       Impact factor: 5.948

4.  Impact of Antibodies That React With Liver Tissue and Donor-Specific Anti-HLA Antibodies in Pediatric Idiopathic Posttransplantation Hepatitis.

Authors:  Yoshihiro Hirata; Atsushi Yoshizawa; Hiroto Egawa; Daisuke Ueda; Shinya Okamoto; Hideaki Okajima; Kimiko Yurugi; Rie Hishida; Hideyo Hirai; Aya Miyagawa-Hayashino; Taira Maekawa; Hironori Haga; Sinji Uemoto
Journal:  Transplantation       Date:  2017-05       Impact factor: 4.939

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.